Brentuximab Vedotin

Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.

Also Known As:

Adcetris; CAC10-1006; SGN-35; cAC10-vcMMAE; CAC10 1006; CAC101006; SGN 35; SGN35; cAC10 vcMMAE; cAC10vcMMAE

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Blood Proteins: 12679
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Humanized Monoclonal Antibodies: 220
        Brentuximab Vedotin: 825
    - Immunoproteins: 43
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Humanized Monoclonal Antibodies: 220
        Brentuximab Vedotin: 825
  - Globulins: 3119
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Humanized Monoclonal Antibodies: 220
        Brentuximab Vedotin: 825
- Peptides: 84029
  - Oligopeptides: 527
    - Brentuximab Vedotin: 825

Michelle Don Selected Research

Michelle Don Research Topics

Disease

Drug/Important Bio-Agent (IBA)